[Passive smoking and other risk factors associated to the lower respiratory illnesses in sucking infants]

F Galve Royo1, C García Vera, F J Rubio Sevillano

  • 1Centro de Salud Teruel.

Atencion Primaria
|September 19, 1998
PubMed

Insights

Passive smoking, older siblings, and male sex significantly increase lower respiratory illness (LRIs) risk in infants. Shorter breastfeeding durations also correlate with higher LRI incidence during the first year of life.

Area of Science:

  • Pediatrics
  • Epidemiology
  • Public Health

Context:

  • Lower respiratory illnesses (LRIs) are a significant cause of infant morbidity.
  • Identifying risk factors is crucial for prevention strategies.
  • This study examines LRI prevalence and associated factors in infants within their first year of life.

Purpose:

  • To evaluate the frequency of LRIs in the first year of life.
  • To determine the relationship between LRIs and risk factors including passive smoking, feeding methods, and family structure.
  • To assess the impact of sex on LRI incidence.

Summary:

  • A retrospective study of 240 infants found that 37% experienced at least one LRI episode in their first year.
  • Key risk factors identified include passive smoking (OR=1.86), exclusive breastfeeding for less than 5 months (OR=2.1), and having older siblings (OR=3.12).
  • Male infants showed a statistically significant higher number of LRI episodes compared to females (p=0.0489).

Impact:

  • Findings highlight the critical role of environmental factors like passive smoking and socioeconomic factors like family structure in infant respiratory health.
  • Results underscore the protective effect of adequate breastfeeding duration.
  • The study provides evidence for targeted public health interventions to reduce LRI burden in infants.
Abstract

Related Concept Videos

Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...